Regression of metastatic non-small cell lung cancer with low molecular weight heparin

Thrombosis and Haemostasis

Volumn 88, Issue 4, 2002, Pages 686-

  Loynes, James T ^a   Zacharski, Leo R ^a   Rigas, James R ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DEXAMETHASONE; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTINEOPLASTIC ACTIVITY; BEAM THERAPY; BRAIN METASTASIS; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; DRUG EFFECT; FEMORAL VEIN; HUMAN; LEG THROMBOSIS; LETTER; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; BRAIN TUMOR; LUNG TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REMISSION; VEIN THROMBOSIS;

BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; REMISSION INDUCTION; VENOUS THROMBOSIS;

EID: 0036799130     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613276     Document Type: Letter

References (3)

1. Zacharski LR, Ornstein DL, Heparin and cancer. Thromb Haemost 1998; 80: 10-23.
2. Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N Engl J Med 2000; 342 (26): 1953-8.
3. Zacharski LR, Ornstein DL, Mamourian AC. Low-molecular-weight heparin and cancer. Semin Thromb Hemost 2000; 26 Suppl 1: 69-77.